
Sign up to save your podcasts
Or


Cindy Eckert (formally Whitehead) is the founder of a Sprout the first pharmaceutical company to develop Addyi, the first female Viagra. In the mid-2010s, Cindy sold her company to a bigger pharmaceutical company but soon found she made a mistake.
The program Pinkbator is searching for women entrepreneurs wanting to improve the lives of women and the world in general. Cindy is very passionate about her mission and the company she built. She takes me on the journey of Slate (her first pharmaceutical company), Sprout, and finally The Pink Ceiling, She tells me about her billion dollar exit and how her purchaser disappointed her in the end.
Cindy was so disappointed by her company’s “adopted parents” that she sued for the right to take the company back. I ask her how she managed it and she credits creative deal structuring and a great legal team. She won the case and built The Pink Ceiling, a business incubator that is dedicated to empowering, educating, and giving women entrepreneurs a chance to grab capital opportunities.
You need to know what you are passionate about and what you want your company to be. Then you need to align your passion and vision with your investors, employees, and eventually potential buyers. Maintaining this alignment makes all the difference with whether you will be pleased with a sale or not.
GEXP Collaborative
The Pink Ceiling
A self-made serial entrepreneur and vocal advocate for women, Cindy Whitehead-Eckert defies convention. In her industry, in her companies, in her outcomes. Her work today in The Pink Ceiling/Pinkubator continues to break barriers by investing in and mentoring other women to get to her same outcomes. She’s on a mission to make women really rich. You cannot miss Cindy. Everything she touches turns to pink.
Over a distinguished 24-year career in healthcare, in only the last 10 she has started and sold two businesses for more than $1.5B. First Slate Pharmaceuticals, which redefined long-acting testosterone treatment for men then Sprout Pharmaceuticals which broke through with the first ever FDA-approved drug for low sexual desire in women — dubbed “female Viagra” by the media. After selling the company for $1B in 2015, she successfully fought to get the drug back and launch it on her own terms.
Cindy has made waves, and made her own success, creating mission-driven companies that deliver big. Her results have become a widely covered business success story featured in major media outlets. She is most proud of helping others take command. The profoundly positive impact those companies have made in people’s lives is
We discuss how moving to lower tax brackets can save you tons of money on the sale of your company. The catch is, you have to jump through the hoops to keep your previous state off your back. Vincenzo shares what some of the benefits of living abroad are for former business owners and why it isn’t an overnight process. We also explore the pros and cons of asset sales and stock sales. If you are a business owner and have considered moving to “greener pastures” after you sell your company, Vincenzo may have a strategy that will work for you.
I mention an accelerator program with GEXP Collaborative during this episode. Our first event should be in August with more on the way. If you are interested in the accelerator program, then you can reach out to me at [email protected] or LinkedIn. We also have a page on the website with more information.
GEXP Collaborative
Vincenzo Villamena, CPA, is the founder of Global Expat Advisors and Online Taxman, specializing in offshore structuring and US tax for international corporations and individuals.
Prior to starting his own firms, Vincenzo served as a partner at 4 Corners Inc., where he advised high net worth individuals in private equity investing and tax matters.
Vincenzo worked in audit, tax and valuation during his time with PricewaterhouseCoopers, involved in Fortune 100 audit engagements and M&A transactions, giving him the knowledge to perform analysis in valuation, corporate finance, and technical accounting issues.
He has both a Masters of Accounting and Bachelors of Business Administration with
From the publisher's feed